A lump at your Mounjaro injection site: what's normal, what to watch

You've just noticed a lump where you injected — here's what's likely happening

Picture this: you pull the pen away after your weekly Mounjaro injection, and a few hours later there's a pea-sized firmness under the skin. Your first instinct is probably to wonder whether you did something wrong. In most cases, you didn't. When a viscous medicine like tirzepatide is delivered into the subcutaneous tissue, the body occasionally responds with localised swelling as the surrounding cells adjust to the new depot of fluid. This is a normal inflammatory process, your immune system noticing something unfamiliar and sending a small response team.

The lump after a Mounjaro injection typically peaks within 24 to 48 hours and then gradually softens as the medicine disperses and the local response calms. It may be faintly tender to the touch and occasionally a little red on the surface. That level of reaction, while annoying, sits firmly in the expected category according to the Mounjaro Patient Information Leaflet. Injection-site reactions are listed as common side effects across the tirzepatide clinical programme and were noted in trial participants regularly.

What shifts the picture is shallow injection. Tirzepatide is designed for the subcutaneous layer (the fatty tissue beneath the skin) not the skin itself. If the needle catches the dermal layer rather than going deeper, the medicine has less tissue to spread into and a lump forms more readily. This is especially worth considering if your usual injection site is leaner, like the thigh on someone with very little subcutaneous fat in that area.

A quick check you can do right now: look at where you injected last week, and where you injected the week before. If they're within a centimetre of each other, you've likely found your answer.

Why rotation matters more than most people realise

Lipohypertrophy is a word that doesn't come up in most conversations, but it's the formal name for the lumpy, thickened patches that build up when any injectable medicine is repeatedly delivered into exactly the same spot. It's well-documented with insulin use, and the same principle applies to Mounjaro. Repeated micro-trauma to the same small area of subcutaneous tissue changes the fat cells there, they enlarge and cluster, creating a firm, rubbery area that can become permanent if the habit continues.

The practical consequence, beyond the cosmetic, is that medicine absorbed through altered fat tissue may behave differently. Absorption can become erratic, which is the opposite of what a once-weekly precision dosing schedule needs.

Rotating injection sites properly means two things. First, cycle between the three licensed body areas: abdomen (staying two inches from the navel), thigh (outer, mid-section), and upper arm (posterior aspect, ideally with assistance or an auto-inject technique). Our guidance on the upper arm as an injection site covers technique for that location specifically. Second, within each area, move each injection at least 2–3 cm from the spot used last time. Keeping a simple mental note of last week's location is enough, no chart required.

If you're seeing a recurring lump after your Mounjaro injection in the same place, that is the rotation habit worth addressing first. Switch body area entirely for the next two or three doses and see whether the lump still forms. Most people find it doesn't.

When a lump at the injection site is worth reporting

The reassuring answer is that the vast majority of Mounjaro injection site lumps resolve without any intervention. The less reassuring (but important) reality is that a small number represent something that warrants clinical review.

Contact your prescriber or a healthcare professional if the lump: grows rather than shrinks after 48 hours; becomes noticeably warm to the touch or significantly more painful over time; develops a spreading redness that extends beyond the immediate injection area; or if you feel generally unwell at the same time. These patterns can indicate a localised skin infection (cellulitis), which needs prompt assessment and sometimes antibiotic treatment. It is rare, but ignoring it makes it considerably harder to treat.

Allergic reactions are also possible, though uncommon. A reaction that goes beyond the injection site (itching, hives or swelling elsewhere, difficulty breathing, or a racing heart) is a medical emergency. Call 999 or go to A&E. The MHRA's Yellow Card scheme is the route to formally report any suspected side effect from a prescription medicine, and patients can submit reports directly.

If you are already a patient at a GPhC-registered pharmacy and you are uncertain whether your reaction needs attention, reaching out to the prescribing team is always appropriate. Aftercare isn't a hurdle. The broader clinical picture for lumps after injecting Mounjaro covers additional scenarios in more detail, and our guidance on a red injection site addresses the specific situation where redness is the primary concern.

Practical steps and when to consider getting clinical support

If a lump has appeared and there are no infection signs, the practical advice is straightforward: do not re-inject into or near that area until it has fully resolved. Apply a cool compress for short intervals in the first 24 hours if it's tender. Avoid pressing or squeezing it, that won't help it disperse and may increase local irritation.

Going forward, using a fresh needle for every injection reduces the friction and slight barbing that a used needle tip develops, both of which can worsen tissue response. Clean the site with an alcohol swab beforehand and allow it to dry fully before injecting, wet skin slightly increases discomfort and can affect how smoothly the pen delivers.

Technique aside, if you're finding that lumps appear after most injections despite good rotation, or if any aspect of your treatment is feeling uncertain, that's worth raising at your next clinical review. You can also check general injection technique guidance for Mounjaro to make sure nothing in your process has drifted from best practice. Mounjaro is a prescription medicine, and questions about your specific experience belong in a conversation with your prescriber, not a search engine.

If you haven't yet started treatment and are weighing up your options, check your eligibility with our prescribers, the consultation is free, and clinical suitability is assessed by a real clinician on the same day.